Bender Robert & Associates Vertex Pharmaceuticals Inc Transaction History

Bender Robert & Associates

$455 Million
Q2 2024

A detailed history of Bender Robert & Associates transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bender Robert & Associates holds 27,288 shares of VRTX stock, worth $12.4 Million. This represents 2.81% of its overall portfolio holdings.

Number of Shares

27,288

Previous 28,172 3.14%

Holding current value

$12.4 Million

Previous $11.8 Million 8.61%

% of portfolio

2.81%

Previous 2.76%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	SELL	$407.69 - $446.08 $154,106 - $168,618	-378 Reduced 1.32%	28,172 $11.8 Million
Q4 2023 Jan 31, 2024	BUY	$343.0 - $410.68 $32,928 - $39,425	96 Added 0.34%	28,550 $11.6 Million
Q3 2023 Oct 13, 2023	BUY	$338.18 - $362.46 $15,894 - $17,035	47 Added 0.17%	28,454 $9.89 Million
Q2 2023 Jul 13, 2023	SELL	$314.42 - $351.91 $135,200 - $151,321	-430 Reduced 1.49%	28,407 $10 Million
Q1 2023 Apr 20, 2023	SELL	$283.23 - $323.1 $6,231 - $7,108	-22 Reduced 0.08%	28,837 $9.09 Million
Q4 2022 Feb 02, 2023	BUY	$285.76 - $321.48 $1,428 - $1,607	5 Added 0.02%	28,859 $8.33 Million
Q3 2022 Oct 26, 2022	BUY	$273.83 - $305.53 $187,025 - $208,676	683 Added 2.42%	28,854 $8.35 Million
Q2 2022 Jul 19, 2022	SELL	$234.96 - $292.55 $63,674 - $79,281	-271 Reduced 0.95%	28,171 $7.94 Million
Q1 2022 Apr 14, 2022	SELL	$221.42 - $260.97 $369,328 - $435,297	-1,668 Reduced 5.54%	28,442 $7.42 Million
Q3 2021 Nov 09, 2021	BUY	$181.39 - $202.99 $760,931 - $851,543	4,195 Added 16.19%	30,110 $5.46 Million
Q3 2021 Nov 03, 2021	SELL	$181.39 - $202.99 $810,450 - $906,959	-4,468 Reduced 14.71%	25,915 $9.35 Million
Q2 2021 Jul 16, 2021	BUY	$187.49 - $221.1 $44,622 - $52,621	238 Added 0.79%	30,383 $6.13 Million
Q1 2021 Apr 28, 2021	BUY	$207.02 - $241.31 $6.24 Million - $7.27 Million	30,145 New	30,145 $6.48 Million

Others Institutions Holding VRTX

# of Institutions

1,706

Shares Held

225M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $117B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bender Robert & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Bender Robert & Associates with notifications on news.

Account

Bender Robert & Associates Vertex Pharmaceuticals Inc Transaction History